Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

for
HR-HPV Testing
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18 - 65

Code: NCT06843720

Recruiting

ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

for
Squamous Cell Carcinoma of Oropharynx, HPV Positive Cancer,
Location: Carmel IN, Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06915038

Recruiting

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

for
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05504707

Phase 1, Recruiting

A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

for
CIN - Cervical Intraepithelial Neoplasia, CIN 1, CIN 2, HPV,
Location: London
Sponsor: Papillex Inc.

Sex: Female

Age: 25 - 55

Code: NCT06979180

Recruiting

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

for
Influenza Prevention, Pandemic Influenza Prevention
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 50

Code: NCT07111078

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

for
Oropharyngeal Squamous Cell Carcinoma,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07044635

Phase 2, Recruiting

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

for
Hormone-receptor-positive Breast Cancer,
Location: Iowa City IA, Houston TX, Seattle WA
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06756932

Phase 1, Recruiting

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families

for
Substance Abuse, Intimate Partner Violence (IPV),
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 12 - 70+

Code: NCT06627764

Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Boston MA, New Haven CT, Washington D.C. DC, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase 1, Recruiting

CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera

for
Typhoid and/or Cholera Vaccination
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT03705585

Recruiting

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

for
Breast Cancer, HER2-positive Breast Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07459673

Phase 2, Recruiting

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy,
Location: Bethesda MD, Little Rock AR, Seattle WA
Sponsor: Precigen, Inc

Sex: All

Age: 18+

Code: NCT06157151

Phase 2, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

Prostate Cancer Genetic Risk Evaluation and Screening Study

for
Prostatic Neoplasm, Prostate Cancer, BRCA2 Mutation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 35+

Code: NCT05129605

Recruiting

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

for
HER2-negative Breast Cancer, Metastatic Breast Cancer,
Location: Bethesda MD, Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05660083

Phase 2, Recruiting

HER2-positive Breast Cancer Registry

for
HER2 + Breast Cancer
Location: Westwood KS
Sponsor: Priyanka Sharma

Sex: All

Age: 18+

Code: NCT06603597

Recruiting

Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B

for
Chronic Hepatitis B
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT06154278

Phase 2, Recruiting

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

for
Breast Cancer, Breast Cancer Female,
Location: Boston MA, Durham NC, Miami FL
Sponsor: Nancy Lin, MD

Sex: All

Age: 18+

Code: NCT06176261

Phase 2, Recruiting

VS-6766+Abema+Fulv in Met HR+/HER- BC

for
Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Boston MA
Sponsor: Adrienne G. Waks

Sex: All

Age: 18+

Code: NCT05608252

Phase 1, Phase 2, Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Durham NC, Columbus OH, Nashville TN, Denver CO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase 1, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial